Adalimumab is used to treat certain inflammatory diseases like rheumatoid arthritis. Humira contributed $21.2 billion in sales to AbbVie fo...

In Europe itself, biosimilars is almost a $4.5-bn opportunity and there are going to be only 3-4 players